Crizotinib neuroblastoma study 'very promising' – Nursing Times
Crizotinib neuroblastoma study 'very promising'Nursing TimesResearchers at The Institute of Cancer Research in London used crizotinib with mTOR inhibitors to overcome the resistance of cancer cells, the paper published in the journal Cancer Cel…